IDE offers global equity exposure to infrastructure, industrials, and materials sectors, with a 9.86% forward yield. Read why IDE CEF is rated a Buy.
Secure, scalable, multi-cloud platform using federated learning aims to accelerate cancer discoveries and treatments SEATTLE, WASHINGTON / ACCESS Newswire / October 1, 2025 / The Cancer AI Alliance ...
HAYWARD, CALIFORNIA / ACCESS Newswire / October 1, 2025 / Biolog, Inc., a trusted leader in microbial identification and testing, today announced its new Foodborne Pathogen Testing Service, out of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback